N-α-Fmoc-N-ω-2,2,5,7,8-pentamethylchroman

Online Inquiry

CAT#CP00222
CAS157774-30-6
Synonyms/AliasFmoc-D-Arg(Pmc)-OH;157774-30-6;C35H42N4O7S;AmbotzFAA1306;SCHEMBL2366956;SCHEMBL13227678;CTK8E9920;MolPort-006-705-561;ACT09751;ZINC4544420;CF-554;AKOS015910376;RTR-006639;AK-81178;KB-301263;TR-006639;FT-0679695;X5799;I14-40191;(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-5-[3-(2,2,5,7,8-pentamethyl-3,4-dihydro-1-benzopyran-6-ylsulfonyl)carbamimidamido]pentanoicacid;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(3-((2,2,5,7,8-pentamethylchroman-6-yl)sulfonyl)guanidino)pentanoicacid;(R,E)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(N'-((2,2,5,7,8-pentamethylchroman-6-yl)sulfonyl)formohydrazonamido)pentanoicacid;N-alpha-(9-Fluorenylmethoxycarbonyl)-N'-(2,2,5,7,8pentamethylchroman-6-sulfonyl)-D-arginnine
M.F/FormulaC35H42N4O7S
M.W/Mr.662.8
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Dulaglutide, sold under the brand name Trulicity, is a GLP-1 receptor agonist which is a class of medications th ...

 Ziconotide (previously called SNX-111), currently marketed under the brand name of Prialt, is the synthetic form ...

  Etomidate, a highly selective intravenous anesthetic agent, was first synthesized at Janssen Pharmaceuticals in ...

of skin aging Skin aging is an obvious external manifestation of the natural process occurring in tissues and or ...

 Urantide is a UⅡ receptor antagonist. It can effectively alleviate monocrotaline (MCT)-induced PAH in a rat mode ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.